Clinical Trial Update: eCoin for OAB Feasibility Follow-on Study [NA]

View source ↗

Summary

A completed feasibility follow-on study of eCoin for overactive bladder and urge urinary incontinence; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urge Incontinence

Drugs mentioned

• eCoin

Snippet

Sponsor: Valencia Technologies Corporation | Conditions: Overactive Bladder, Urge Incontinence | NA | Status: COMPLETED | Results posted: 2021-04-26